Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
Author:
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – CAPES.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
http://link.springer.com/article/10.1007/s10067-018-4169-0/fulltext.html
Reference31 articles.
1. Urowitz MB, Bookman AA, Koehler BE et al (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225
2. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337
3. Du Pasquier S, Aslani P (2008) Concordance-based adherence support service delivery: consumer perspectives. Pharm World Sci PWS 30:846–853. https://doi.org/10.1007/s11096-008-9237-0
4. Lee NL, Yu C-M, Lam Y-Y, Lee VW, Yan BP (2013) Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting. Int J Cardiol 166:278–279. https://doi.org/10.1016/j.ijcard.2012.09.147
5. Costenbader KH, Karlson EW, Gall V, Pablo P, Finckh A, Lynch M, Bermas B, Schur PH, Liang MH (2005) Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum 53:718–723. https://doi.org/10.1002/art.21441
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of dyslipidemia in special groups;Indian Heart Journal;2024-03
2. The Risk Factors for Lupus Nephritis;2023-12-29
3. Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations;Rheumatology International;2023-09-17
4. Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study;Rheumatology;2023-07-13
5. Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus;Clinical Rheumatology;2023-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3